Creative Medical Technology Holdings, Inc. (CELZ): History, Ownership, Mission, How It Works & Makes Money

Ever wondered how a biotech company tackles regenerative medicine and aims to revolutionize treatment for conditions like diabetes and chronic pain? Creative Medical Technology Holdings, Inc. (CELZ), a clinical-stage biotechnology company, is pioneering regenerative medicine solutions across various fields, including immunotherapy, urology, neurology, endocrinology, and orthopedics. Keep reading to explore the history, ownership, mission, operational mechanisms, and revenue streams that define this innovative company and understand its potential impact on the future of healthcare.

Creative Medical Technology Holdings, Inc. (CELZ) History

Creative Medical Technology Holdings, Inc. Founding Timeline

Year established

Creative Medical Technology Holdings, Inc. was founded in 2011.

Original location

The company is headquartered in Scottsdale, Arizona.

Founding team members

The details of the original founding team members are not available in the provided search results.

Initial capital/funding

Information about the initial capital or funding is not available in the provided search results.

Creative Medical Technology Holdings, Inc. Evolution Milestones

Creative Medical Technology Holdings, Inc. Transformative Moments

Creative Medical Technology Holdings, Inc. has navigated several transformative moments that have significantly shaped its trajectory.

• Strategic Shift to Immunotherapy: The acquisition and development of immunotherapy patents and platforms, such as ImmCelz®, marked a pivotal expansion into cancer treatment, diversifying the company's focus beyond regenerative medicine.
• Clinical Validation Initiatives: Initiating clinical trials for products like StemSpine® and CELZ-100 was crucial in moving from theoretical applications to real-world testing, providing data to support the efficacy and safety of their therapies.
• Focus on Intellectual Property: Securing key patents related to their technologies has been essential in protecting their innovations and creating a competitive advantage in the market.

For more insights into the company's guiding principles, explore Mission Statement, Vision, & Core Values of Creative Medical Technology Holdings, Inc.

Creative Medical Technology Holdings, Inc. (CELZ) Ownership Structure

Understanding the ownership structure of Creative Medical Technology Holdings, Inc. (CELZ) provides insights into its control and governance.

Creative Medical Technology Holdings, Inc. (CELZ) Current Status

Creative Medical Technology Holdings, Inc. is a publicly traded company, meaning its shares are available for purchase by the general public on stock exchanges.

Creative Medical Technology Holdings, Inc. (CELZ) Ownership Breakdown

The ownership of Creative Medical Technology Holdings, Inc. (CELZ) is distributed among various shareholders, including institutional investors, individual shareholders, and company insiders. The following table summarizes the ownership breakdown:

Creative Medical Technology Holdings, Inc. (CELZ) Leadership

The leadership team guides the strategic direction and operations of Creative Medical Technology Holdings, Inc. As of April 2025, key members include:

• Timothy Warbington serves as the President and CEO.
• Donna Ittner is the Chief Financial Officer.

For more insights into the company's goals and values, explore: Mission Statement, Vision, & Core Values of Creative Medical Technology Holdings, Inc. (CELZ).

Creative Medical Technology Holdings, Inc. (CELZ) Mission and Values

Creative Medical Technology Holdings, Inc. aims to impact healthcare through biotechnology. You can explore more about their Mission Statement, Vision, & Core Values of Creative Medical Technology Holdings, Inc. (CELZ).

Creative Medical Technology Holdings, Inc.'s Core Purpose

Official mission statement

Creative Medical Technology Holdings does not have a clearly defined official mission statement readily available in its latest filings or investor presentations. Information regarding the company's mission can be inferred from their activities and goals as expressed in their reports.

Based on available information, the inferred components of their mission include:

• Developing novel approaches to regenerative medicine.
• Focusing on unmet needs in areas with limited or ineffective treatment options.
• Advancing technologies that have the potential to improve patient outcomes.

Vision statement

Creative Medical Technology Holdings, Inc. does not have a clearly defined vision statement readily available in its latest filings or investor presentations. However, the vision can be inferred from the company's activities and goals as expressed in their reports.

The inferred components of their vision include:

• Becoming a leader in the field of regenerative medicine.
• Transforming treatment paradigms for various diseases through innovative technologies.
• Creating value for shareholders through the successful development and commercialization of its products.

Company slogan/tagline

There is no specific, publicly advertised slogan or tagline for Creative Medical Technology Holdings, Inc. Recent information, including the latest corporate presentations and news articles through April 2025, does not provide a specific tagline.

Creative Medical Technology Holdings, Inc. (CELZ) How It Works

Creative Medical Technology Holdings, Inc. focuses on biotechnology and is working on immune modulation using its patented technologies in order to combat various diseases, with a particular emphasis on regenerative medicine.

Creative Medical Technology Holdings, Inc.'s Product/Service Portfolio

While specific product details may evolve, Creative Medical Technology Holdings, Inc. generally concentrates on developing and commercializing technologies and therapies in the regenerative medicine space. The table below represents a general overview of potential offerings based on the company's focus:

Creative Medical Technology Holdings, Inc.'s Operational Framework

Creative Medical Technology Holdings, Inc. operates through several key processes to create value:

• Research and Development: Investing in R&D to discover and develop new regenerative medicine and immune modulation technologies.
• Patenting Technologies: Securing intellectual property rights for its inventions to protect its market position.
• Clinical Trials: Conducting clinical trials to evaluate the safety and efficacy of its therapies.
• Partnerships and Collaborations: Collaborating with other companies and research institutions to accelerate the development and commercialization of its products.
• Licensing Agreements: Potentially licensing its technologies to other companies for further development and commercialization.

For more insights into the company's investor profile, you might find this resource helpful: Exploring Creative Medical Technology Holdings, Inc. (CELZ) Investor Profile: Who’s Buying and Why?

Creative Medical Technology Holdings, Inc.'s Strategic Advantages

Creative Medical Technology Holdings, Inc. may leverage several strategic advantages to achieve success in the market:

• Patented Technologies: Owning exclusive rights to innovative technologies in regenerative medicine.
• Focus on Unmet Needs: Addressing diseases and conditions with limited treatment options.
• Experienced Management Team: A leadership team with expertise in biotechnology, clinical development, and commercialization.
• Strategic Partnerships: Collaborations that provide access to resources, expertise, and markets.

Creative Medical Technology Holdings, Inc. aims to translate its research and development efforts into commercially viable products that improve patient outcomes and generate value for its stakeholders.

Creative Medical Technology Holdings, Inc. (CELZ) How It Makes Money

Creative Medical Technology Holdings, Inc. focuses on developing biotechnology products in the fields of urology, gynecology, and immunology, aiming to address unmet medical needs and generate revenue through the commercialization of these innovative therapies.

Creative Medical Technology Holdings, Inc.'s Revenue Breakdown

As of now, specific details on the revenue breakdown (such as percentage of total revenue from each stream and growth trends) for Creative Medical Technology Holdings, Inc. are not available in the provided search results for the fiscal year 2024. Financial data is often detailed in company's financial reports.

Creative Medical Technology Holdings, Inc.'s Business Economics

Creative Medical Technology Holdings, Inc. operates under a business model centered on:

• Developing and patenting novel medical technologies.
• Conducting clinical trials to validate the safety and efficacy of their products.
• Seeking regulatory approvals from bodies like the FDA to bring products to market.
• Establishing partnerships for manufacturing, distribution, and commercialization to maximize market reach.

The economic fundamentals of the company are influenced by factors such as:

• The success rate of clinical trials, which significantly impacts the valuation of their intellectual property.
• The regulatory landscape, which can either accelerate or delay the market entry of their products.
• Market demand for their products, particularly in specialized areas like urology and immunology.

For more insights into the company's values, see: Mission Statement, Vision, & Core Values of Creative Medical Technology Holdings, Inc. (CELZ).

Creative Medical Technology Holdings, Inc.'s Financial Performance

Analyzing Creative Medical Technology Holdings, Inc.'s financial performance involves considering these key aspects:

• R&D Expenditure: A significant portion of the company's finances is likely allocated to research and development, reflecting its commitment to innovation.
• Cash Runway: Monitoring the company's cash reserves against its burn rate is crucial for assessing its ability to fund ongoing operations and research.
• Partnerships and Licensing: Revenue from partnerships, licensing agreements, or government grants can provide vital capital to offset expenses.
• Stock Performance: Evaluating stock trends and investor confidence can provide insights into market perception of the company’s prospects.

As of April 2025, detailed financial figures for the fiscal year 2024, such as revenue, net income, and specific growth metrics, were not available in the search results. For a comprehensive financial analysis, refer to Creative Medical Technology Holdings, Inc.'s official financial statements and investor relations materials.

Creative Medical Technology Holdings, Inc. (CELZ) Market Position & Future Outlook

Creative Medical Technology Holdings, Inc. faces a dynamic market landscape with opportunities for growth balanced by inherent challenges in the biotechnology sector. The company's future success hinges on its ability to navigate regulatory hurdles, secure funding, and demonstrate clinical efficacy of its stem cell-based therapies.

Competitive Landscape

The regenerative medicine market is competitive, with several players vying for market share. Creative Medical Technology Holdings operates in this space alongside other companies with varying approaches and strengths. The following table provides a hypothetical overview of the competitive landscape:

Opportunities & Challenges

Creative Medical Technology Holdings, Inc. has several opportunities balanced by potential risks that could impact future performance.

Industry Position

Creative Medical Technology Holdings operates within the evolving regenerative medicine industry. Its standing can be understood through the following points:

• The company focuses on stem cell therapies, a segment with high growth potential but also significant regulatory scrutiny.
• Its success depends on securing additional funding to advance its clinical programs.
• The company's intellectual property portfolio is a key asset, providing a competitive edge in the development of novel therapies.

For more insights into the investment profile of Creative Medical Technology Holdings, explore: Exploring Creative Medical Technology Holdings, Inc. (CELZ) Investor Profile: Who’s Buying and Why?